Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 5, 2008, Pages 406-414

  Perez R ^a   Palma, C ^a   Nunez M J ^a   Cox, J ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN;

AMNION FLUID; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; EWE; FEMALE; FETOPLACENTAL UNIT; FETUS; FETUS BLOOD; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MATERNAL BLOOD; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL;

ANIMALS; ANTIPARASITIC AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FETAL BLOOD; FETUS; HALF-LIFE; INJECTIONS, INTRAVENOUS; IVERMECTIN; MATERNAL-FETAL EXCHANGE; METABOLIC CLEARANCE RATE; PREGNANCY; PREGNANCY, ANIMAL; SHEEP;

OVIS ARIES;

EID: 53149112763     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00971.x     Document Type: Article

References (48)

1. Alvinerie, M. Lespine, A. (2006) Drug transporters and disposition of milbemycins and avermectins. Journal of Veterinary Pharmacology and Therapeutics, 29 (Suppl. 1 64 66.
2. Alvinerie, M., Dupuy, J., Eeckhoute, C. Sutra, J.F. (1999) Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant reversing agent verapamil. Parasitology Research, 85, 920 922.
3. Atkinson, D.E., Sibley, C.P., Farbairn, L.J. Greenwood, S.L. (2006) Placenta, 27, 707 714.
4. Audus, K.L. (1999) Controlling drug delivery across the placenta. European Journal of Pharmaceutical Sciences, 8, 161 165.
5. Ballent, M., Lifschitz, A., Virkel, G., Sallovitz, J. Lanusse, C. (2007) Involvement of P-Glycoprotein on ivermectin kinetic behaviour in sheep: itraconazde-mediated changes on gastrointestinal disposition. Journal of Veterinary Pharmacology and Therapeutic, 30, 242 248.
6. Campbell, W.C. Benz, G.W. (1984) Ivermectin: a review of efficacy and safety. Journal of Veterinary Pharmacology and Therapeutics, 7, 1 16.
7. Chamberlain, P.L., Fowler, B.A., Sexton, M.J., Peggins, J.O. von Bredow, J. (2003) Preliminary studies of offpring exposure to phenylbutazone and ivermectin during the perinatal period in the Holstein cow-calf model. Toxicology and Applied Pharmacology, 187, 198 208.
8. Chiu, S.-H.L. Lu, A.Y.H. (1989) Metabolism and tissue residues. In Ivermectin and Abamectin. Ed. Campbell, W.C., Chapter 8, pp. 131 143. Springer Verlag, New York.
9. Chiu, S.L., Green, M.L., Baylis, F.P., Eline, D., Meriwether, H. Jacob, T.A. (1990) Absorption, tissue distribution and excretion of tritium-labeled ivermectin in cattle, sheep and rat. Journal of Agricultural and Food Chemistry, 38, 2072 2078.
10. Davis, L.E. Koritz, G.D. (1983) Placental transfer of drug in ruminant models. In Veterinary Pharmacology and Toxicology. Eds Ruckebusch, y., Toutain, P.L. Koritz, G.D., pp. 23 38. MTP Press Limited, Lancaster.
11. De Montigny, P., Shim, J.S.K. Pivinichny, J.V. (1990) Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent. Journal of Pharmaceutical and Biomedical Analysis, 8, 507 511.
12. Dupuy, J., Larrieu, G., Sutra, J.F., Lespine, A. Alvinerie, M. (2003) Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Veterinary Parasitology, 112, 337 347.
13. Farrier, D. (1997) PK Solutions. Non-Compartmental Pharmacokinetics Data Analysis. User Guide, pp. 50. Summit Research Services, Ashland, OH, USA.
14. Fink, D.W. Porras, A.G. (1989) Pharmacokinetics of ivermectin in animal and humans. In Ivermectin and Abamectin. Ed. Campbell, W.C., Chapter 7, pp. 113 130. Springer-Verlag, New York.
15. Fisher, M.H. Mrozik, H. (1989) Chemistry. In Ivermectin and Abamectin. Ed. Campbell, W.C., Chapter 1, pp. 1 23. Springer-Verlag, New York.
16. Frederiksen, M.C. (2001) Physiologic changes in pregnancy and their effect on drug disposition. Seminars in Perinatology, 25, 120 123.
17. Gedeon, E. Koren, G. (2005) Designing pregnancy centered medications: drugs, which do not cross the human placenta. Placenta, 27, 861 868.
18. Gedeon, C., Behravan, J., Koren, G. Piquette-Miller, M. (2006) Transport of gliburide by placental ABC transporters: implications in fetal drug exposure. Placenta, 27, 1096 1102.
19. Gentry, P.L., Covington, T.R. Clewel, H.J. (2003) Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Regulatory Toxicology and Pharmacology, 38, 1 16.
20. Grimshaw, W.T.R., Hong, C. Hunt, K.R. (1997) Persistent activity of injectable ivermectin against important gastrointestinal nematodes of sheep. Veterinary Record, 141, 422 424.
21. Halley, B.A., Nessel, R.J. Lu, A.Y.H. (1989) Environmental aspect of use of ivermectin in livestock: general considerations. In Ivermectin and Abamectin. Ed. Campbell, W.C., Chapter 11, pp. 162 172. Springer Verlag, New York.
22. Hennessy, D.R. Alvinerie, M.R. (2002) Pharmacokinetics of the macrocyclic lactones: conventional wisdom and new paradigm. In Macrocyclic Lactones in Antiparasitic Therapy. Eds Vercruyss, E.J. Rew, R.S., Chapter 2, pp. 97 123. CAB International, Wallingford.
23. Kumar, S., Tonn, G., Riggs, W. Rurak, D.W. (2000) Diphenhydramine disposition in the sheep maternal-placental-fetal unit: gestational age, plasma drug protein binding and umbilical blood flow effects on clearance. Drug Metabolism and Disposition, 28, 279 285.
24. Lankas, G.R., Cartwright, M.E. Umbenhauer, D. (1997) P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicology and Applied Pharmacology, 143, 357 365.
25. Lankas, G.R., Wise, L.D., Cartwright, M.E., Pippert, T. Umbenhauer, D.R. (1998) Placental p-glycoprotein deficiency enhances susceptibility to chemically induced birth defect in mice. Reproductive Toxicology, 12, 457 463.
26. Lespine, A., Dupuy, J., Orlowski, S., Nagy, T., Glavinas, H., Krajcsi, P. Alvinerie, M. (2006) Interaction of ivermectin with multidrug resistance proteins (MRP 1, 2 and 3). Chemico-Biological Interactions, 159, 169 179.
27. Lo, P.A., Fink, D.W., Williams, J.B. Blodinger, J. (1985) Pharmacokinetic studies of ivermectin: effects of formulation. Veterinary Research Communications, 9, 251 268.
28. McKellar, Q.A. Benchaoui, H.A. (1996) Avermectins and milbemycins. Journal of Veterinary Pharmacology and Therapeutics, 19, 331 351.
29. Molento, M.B., Lifschitz, A., Sallovitz, J., Lanusse, C. Prichard, R. (2004) Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep. Parasitology Research, 92, 121 127.
30. Morgan, D.J. (1997) Drug disposition in mother and fetus. Clinical and Experimental Pharmacology and Physiology, 25, 869 873.
31. Myllynen, P., Pienimäki, P. Vähäkangas, K. (2005) Human placental perfusion method in the assessment of transplacental passage of antiepileptic drugs. Toxicology and Applied Pharmacology, 207, S489 S494.
32. Novotna, M., Libra, A., Kopeck, M., Pavek, P., Fendrich, Z., Semecky, V. Stand, F. (2004) P-glycoprotein expression and distribution in the rat placenta during pregnancy. Reproductive Toxicology, 18, 782 792.
33. Nowakowski, M., Lynch, M., Smith, D., Logan, N., Mouzin, D., Lukaszewicz, J., Ryan, N., Hunter, R. Jones, R. (1995) Pharmacokinetics and bioequivalence of parenterally administered doramectin in cattle. Journal of Veterinary Pharmacology and Therapeutics, 18, 290 298.
34. Paveck, P., Stand, F., Fendrich, Z., Slenarova, H., Libra, A. Novotna, M. (2003) Examination of the functional activity of P-glicoprotein in the rat placental barrier using rhodamine 123. Journal of Pharmacology and Experimental Therapeutic, 305, 1239 1250.
35. Perez, R., Espinoza, M., Riquelme, R., Parer, J.T. Llanos, A.J. (1989) Arginine vasopressin mediates cardiovascular responses to hypoxemia in fetal sheep. American Journal of Physiology, 256, R1011 R1018.
36. Pérez, R., Palma, C., Cabezas, I., Araneda, M., Rubilar, L. Arboix, M. (2007) Gastrointestinal parasitism reduces the plasmatic availability of doramectin in lambs. Veterinary Journal, 173, 169 175.
37. Pérez, R., Palma, C., Nuñez, M.J., Cox, J. Arboix, M. (2008) Pharmacokinetics of ivermectin in pregnant and non pregnant sheep. Journal of Veterinary pharmacology and Therapeutics, 31, 71 76.
38. Pouliot, J.F., L'Hereux, F., Liu, Z., Prichard, R.K. Georges, E. (1997) Reversal P-glycoprotein-associated multidrug resistance by ivermectin. Biochemical Pharmacology, 53, 17 25.
39. Ruckebusch, Y. (1983) Perinatal pharmacology in ruminants models. In Veterinary Pharmacology and Toxicology. Eds Ruckebusch, Y., Toutain, P.L. Koritz, G.D., pp. 3 22. MTP Press Limited, Lancaster.
40. Santos, A.C., Arthur, G.R., Lehning, E.J. Finster, M. (1997) Comparative pharmacokinetics of ropivacaine and bupivacaine in nonpregnant and pregnant ewes. Anesthesia and Analgesia, 85, 87 93.
41. Schinkel, A.H., Wagenaar, E., Van Deenter, L., Mol, C.A.A.M. Borst, P. (1995) Absence of mdr1a P-glycoprotein in mice affect tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporine A. Journal of Clinical Investigation, 96, 1698 1705.
42. Shiverick, K.I., Slikker, W., Rogerson, S.J. Miller, K. (2003) Drugs and the placenta: a workshop. Placenta, 24 (Suppl. A 555 559.
43. Sklavounos, C., Dmers, N., Lukaszewicks, J. Nowakowski, M. (1994) Photoisomerization of aromatic doramectin derivatives. Journal of Agricultural and Food Chemistry, 42, 1228 1231.
44. Smith, A.J., Van Helvoort, A., Van Meer, G., Szabó, K., Welker, E., Szakács, G., Váradi, A., Sarkadi, B. Barst, P. (2000) MDR3 p-glycoprotein, a phosphatidylcholine translocase, transport several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. Journal of Biological Chemistry, 275, 23530 23539.
45. Sun, M., Kingdom, J., Baczyk, D., Lye, S.J., Matthews, S.G. Gibb, W. (2006) Expression of the multidrug resistance P-Glycoprotein, (ABCB1 glycoprotein) in the human placenta decrease with advancing gestation. Placenta, 27, 602 609.
46. Unadkat, J.D., Dahlino, A. Vijay, S. (2004) Placental drug transporters. Current Drug Metabolism, 5, 125 131.
47. Wang, L.H., Rudolph, A.M. Benet, L.Z. (1985) Pharmacokinetics of drug and metabolites in the maternal-placental-fetal unit: General principles. In NIDA Research Monograh 60: Prenatal Drug Exposure: Kinetic and Dynamics. Eds Chiang, C.N. Lee, C.C., pp. 25 37. National Institute on Drug Abuse, Rockville, Maryland.
48. Zajac, A.M., Thathcher, C.D., Brock, R.A., Umberger, S.H. Notter, D.R. (1992) Comparison of ivermectin formulations in an ovine parasite control program. Veterinary Record, 130, 353 354.